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Avoiding EMBRYOS “R” US: Toward a Regulated 
Fertility Industry 
Ann Bindu Thomas∗ 
I. INTRODUCTION 
Envision a couple discovering that their embryos, stored in a 
fertility clinic for future implantation, have been sold for research 
purposes without their consent. Or worse, that the fertility clinic sold 
or gave their embryos to another couple—a couple that has now 
birthed the unwitting donors’ biological child.1 Federal oversight 
addressing the disposition of embryos is nearly nonexistent,2 making 
the opportunity for such scenarios to occur uncomfortably likely, 
with little legal recourse for the harmed couple.  
Assisted reproductive technology (“ART”) has created a booming 
fertility industry. One ART method has given couples the possibility 
to have biological children through implantation of embryos created 
outside the womb.3 With this advancement come many opportunities 
for misuse or inappropriate disposition of human embryos. This Note 
proposes that the utilization of human embryos and the organizations 
that hold them should be closely regulated to ensure that the parents 
of an embryo are the ones who decide the embryo’s final disposition 
and are protected from exploitation.4 
In Part II, this Note will examine embryo donation and current 
regulations. Because the ethical issues surrounding human embryo 
 
 ∗ J.D. (2008), Washington University School of Law. My sincerest thanks and 
appreciation to Wayne Liang for his helpful comments; to Professor Rebecca Dresser, who 
sparked my interest in law and bioethics; to my family for their unfailing support; and to the 
editorial staff of the Washington University Journal of Law & Policy. 
 1. See infra note 26 and accompanying text.  
 2. See infra notes 28–35 and accompanying text.  
 3. See infra notes 5–6 and accompanying text.  
 4. See discussion infra Part VI.  
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procurement are similar to issues in organ or tissue procurement, 
statutory regulations of organ and tissue procurement provide a 
useful framework for the creation of embryo donation policies and 
regulations,. Thus, Part III will discuss organ procurement and its 
regulations while Part IV will do the same for tissues. Part V 
analyzes the impact of following either system in the context of 
human embryo procurement. Finally, Part VI proposes 
recommendations for regulating human embryo procurement that 
protect both donor and embryo. 
II. EMBRYO PROCUREMENT AND REGULATION 
A. Procurement of Embryos 
ART is used to implant human embryos, fertilized outside the 
woman’s womb, into a woman for a couple to birth a biological 
child.5 To create a human embryo, a female egg and male sperm are 
joined through in-vitro fertilization (“IVF”) prior to implantation.6 
This method is normally used if a couple is unable to conceive 
naturally.7 When sperm and egg are successfully joined, the resulting 
embryo is the genetic offspring of the couple.8 The number of human 
embryos produced through an ART process often exceeds the 
“number that can be prudently transferred to the patient at one time.”9 
Couples can store non-transferred human embryos through 
 
 5. See Society for Assisted Reproductive Technology, Assisted Reproductive 
Technologies, http://www.sart.org/Guide_AssistedReproductiveTechnologies.html (last visited 
Apr. 7, 2008) (“[ART] includes in vitro fertilization embryo transfer (IVF-ET), gamete 
intrafallopian transfer (GIFT), zygote intrafallopian transfer (ZIFT), tubal embryo transfer 
(TET), and frozen embryo transfer (FET)” and “[t]hese techniques also apply to oocyte 
donation and gestational carriers.”).  
 6. ASRM: Frequently Asked Questions About Infertility, http://www.asrm.org/Patients/ 
faqs.html#Q5 (last visited Apr. 7, 2008) [hereinafter ASRM: FAQ]. IVF bypasses the fallopian 
tubes and implants the embryo directly into the woman’s uterus. Id. The approximate cost for 
such a procedure is $12,400. Id. IVF accounts for about 99% of ART procedures. Id.  
 7. Couples also choose IVF to screen for genetic diseases. Joe Palca, Screening Embryos 
for Disease (NPR radio broadcast Dec. 20, 2006), available at http://www.npr.org/templates/ 
story/story.php?storyId=6653837. 
 8. ASRM: FAQ, supra note 6.  
 9. David I. Hoffman et al., Cryopreserved Embryos in the United States and Their 
Availability for Research, 79 FERTILITY & STERILITY 1063 (2003).  
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cryopreservation for future pregnancies.10 Almost all cryopreserved 
embryos are kept at the couple’s fertility clinic, unless storage space 
is lacking or necessity dictates otherwise.11  
Human embryos may be donated directly or anonymously.12 
Unlike other human reproductive products that are required by the 
Food and Drug Administration (“FDA”) to be screened and 
quarantined prior to donation, the FDA exempts most testing 
requirements for embryos and oocytes used for reproductive services 
originating between sexually intimate partners.13 Cryopreserved 
embryos are able to be used for the patient’s fertility treatment,14 
donated to research15 or another patient,16 destroyed, or used for 
quality assurance purposes.17 Potential parents are usually 
encouraged to sign pre-procedural agreements indicating their 
 
 10. Id. See Kass v. Kass, 696 N.E.2d 174, 175 (N.Y. 1998) (“Cryopreservation serves to 
reduce both medical and physical costs because eggs do not have to be retrieved with each 
attempted implantation, and delay may actually improve the chances of pregnancy.”). 
Cryopreservation freezes the embryo to preserve it until it is needed. Hoffman, supra note 9, at 
1066. 
 11. Hoffman, supra note 9, at 1066. The majority of fertility clinics have the ability to 
cryopreserve embryos. Id.  
 12. GUIDANCE FOR INDUSTRY: ELIGIBILITY DETERMINATION FOR DONORS OF HUMAN 
CELLS, TISSUES, AND CELLULAR AND TISSUE-BASED PRODUCTS 36–38 (2007), available at 
http://www.fda.gov/cber/gdlns/tissdonor.pdf [hereinafter ELIGIBILITY DETERMINATION]. 
 13. 21 C.F.R. § 1271.90 (2006). See ELIGIBILITY DETERMINATION, supra note 12, at 39–
44. Generally, testing is conducted to ascertain the presence of HIV, Hepatitis B, Hepatitis C, 
Human Transmissible Spongiform Encephalopathy, Treponema Pallidum, communicable 
disease risk associated with xenotransplantation, Chlamydia Trachomatis, and Neisseria 
Gonorrhea in semen or other reproductive cells such as oocytes. Id. at 14–21. Any potential 
recipient of the cryopreserved embryos must be advised that “screening and testing of the 
donors were not performed at the time of cryopreservation of the reproductive cells or tissue, 
but have been performed subsequently.” Id. at 43.  
 14. Cryopreservation allows for future attempts at pregnancy. See Hoffman, supra note 9, 
at 1066. 
 15. Federal law prohibits the use of federal funds for “(1) the creation of a human embryo 
or embryos for research purposes; or (2) research in which a human embryo or embryos are 
destroyed, discarded, or knowingly subjected to risk of injury or death greater than that allowed 
for research on fetuses in utero . . . .” JUDITH A. JOHNSON & ERIN WILLIAMS, STEM CELL 
RESEARCH, CON. RESEARCH SERV. Rep., at 3–7 (2004), available at http://www.fas.org/ 
spp/civil/crs/RL31015.pdf.  
 16. Organizations like Project Snowflakes connect couples who are willing to donate their 
cryopreserved embryos with couples in need of human embryos. Snowflakes Embryo Adoption 
Program, http://www.nightlight.org/snowflakeadoption.htm (last visited Apr. 7, 2008).  
 17. See Hoffman, supra note 9, at 1063, 1066. According to a 2002 study, the vast 
majority of the nearly 400,000 cryopreserved embryos are designated for patient treatment, 
while a very small percentage (2.8%) of the total is available for research. Id.  
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selection between the alternatives.18 If a couple did not create such an 
agreement and cannot be contacted, the cryopreserved embryos are 
considered abandoned.19 In such cases, fertility clinics continue to 
cryopreserve the embryos or destroy the abandoned embryos.20 The 
total number of cryopreserved embryos in United States fertility 
clinics is estimated to be approximately 400,000.21  
Explosive interest in embryonic stem cell research and desperate 
couples desiring to have a birthed child give cryopreserved embryos 
real economic value.22 In fact, purchasing an embryo may be much 
less expensive than undergoing the entire fertility process.23 Unlike 
tissue and organs donation, embryo donation is largely unregulated 
and easily manipulated by a highly profitable fertility industry,24 
which currently rakes in $3.3 billion dollars annually.25 At most, 
states like California provide some protection against embryo 
misappropriation without parental consent.26  
 
 18. See Ethics Committee of the American Society for Reproductive Medicine, 
Disposition of Abandoned Embryos, 82 FERTILITY & STERILITY S253 (2004).  
 19. Id. The ASRM ethics committee opined that an embryo can be considered abandoned 
if “more than five years have passed since contact with a couple, diligent efforts have been 
made by telephone and registered mail to contact the couple at their last known address, and no 
written instruction from the couple exists concerning disposition.” Id. at S253. 
 20. Id. See generally Heidi Forster, The Legal and Ethical Debate Surrounding the 
Storage and Destruction of Frozen Human Embryos, 76 WASH. U. L.Q. 759 (1998).  
 21. Hoffman, supra note 9, at 1068. 
 22. E.g., Rob Stein, ‘Embryo Bank’ Stirs Ethics Fears: Firm Lets Clients Pick Among 
Fertilized Eggs, WASH. POST, Jan. 6, 2007, at A1, available at http://www.washingtonpost. 
com/wp-dyn/content/article/2007/01/05/AR2007010501953.html. Abraham Center of Life 
charges $2,500 per embryo for embryos that are tailor-made, which have an increased value. Id. 
 23. Id. Even with implantation costs, purchasing an embryo would be cheaper than the 
average cost of going through in vitro fertilization. Id.  
 24. See generally Helen M. Alvare, The Case for Regulating Collaborative Reproduction: 
A Children’s Rights Perspective, 40 HARV. J. ON LEGIS. 1, 25–31 (2003) (discussing the “dearth 
of regulation,” with the regulatory interests dealt with unevenly on a state by state basis). 
 25. Steven Kotler, The God of Sperm, LA WEEKLY NEWS, Sept. 26, 2007, available at 
http://www.laweekly.com/news/news/the-god-of-sperm/17290/?page=1.  
 26. See CAL. PENAL CODE § 367g (West 2007). California’s misappropriation law was a 
result of the University of California, Irvine, Center for Reproductive Health fertility scandal. 
Melanie Blum, Embryos and the New Reproductive Technologies, http://www.surrogacy.com/ 
legals/embryotech.html (last visited Apr. 7, 2008). Physicians at the fertility clinic thawed and 
implanted embryos into other couples without parental knowledge or consent. Id. As many as 
five-hundred couples may have been victims of embryo misappropriation through sale or 
transfer without permission. Id. California’s legislators responded by passing § 367g. Id. See 
generally Judith D. Fischer, Misappropriation of Human Eggs and Embryos and the Tort of 
https://openscholarship.wustl.edu/law_journal_law_policy/vol27/iss1/11
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B. Existing Regulations of Embryo Procurement 
Few statutes address human embryo procurement.27 Most pertain 
to either the legal status of embryos28 or the rights of a husband, wife, 
or other party to legal custody of a cryopreserved embryo in the event 
of divorce, death, or other circumstance.29 Custodial rights of these 
parties are often governed by contract law.30 However, at least two 
states have forbidden monetary compensation for embryos 
 
Conversion: A Relational View, 32 LOY. L.A. L. REV. 381 (1999) (discussing the embryo 
misappropriation scandal and the resulting passage of § 367g). 
 27. Id. at 392. See Alvare, supra note 24, at 25–35.  
 28. See, e.g., Davis v. Davis, 842 S.W.2d 588, 597 (Tenn. 1992) (concluding “that 
preembryos are not, strictly speaking, either ‘persons’ or ‘property,’ but occupy an interim 
category that entitles them to special respect because of their potential for human life” and that 
parents do not have a property interest, per se, but rather have an interest in ownership because 
of their “decision-making authority concerning disposition of the preembryos, within the scope 
of policy set by law.”). Louisiana is the only state that explicitly includes embryos, including 
those created through ART, as a judicial person. LA. STAT. ANN. § 9:124 (2006). See also 
Planned Parenthood v. Casey, 505 U.S. 833, 869 (1992) (finding that the State has the power to 
restrict abortions after fetal viability, which indicates that personhood probably begins after a 
fetus is viable); Roe v. Wade, 410 U.S. 113, 162 (1973) (concluding that the term “person” does 
not include the unborn fetus); Susan L. Crockin, Commentary, What Is an Embryo?: A Legal 
Perspective, 36 CONN. L. REV. 1177 (2004) (critically analyzing and discussing Dr. Kiessling’s 
What Is an Embryo?); John A. Robertson, In the Beginning: The Legal Status of Early 
Embryos, 76 VA. L. REV. 437, 450–55 (1990) (discussing the legal status of embryos).  
 29. See In re Marriage of Witten, 672 N.W.2d 768 (Iowa 2003)(holding that agreements 
entered into at the time IVF is commenced are enforceable and binding, subject to the right of 
either party to change his or her mind regarding disposition of embryos and if donors cannot 
reach a mutual decision on disposition, then no transfer, release, disposition, or use of the 
embryos can occur without the signed authorization of both donors); A.Z. v. B.Z., 725 N.E.2d 
1051 (Mass. 2000) (holding that an ex-husband’s interest in avoiding procreation outweighed a 
wife’s interest in having more children using cryopreserved embryos, and public policy dictates 
that husbands not be forced to become parents against their will); J.B. v. M.B., 783 A.2d 707 
(N.J. 2001) (holding that ordinarily the party wishing to avoid procreation should prevail); Kass 
v. Kass, 696 N.E.2d 174 (N.Y. 1998)(stating that parties should be encouraged to specify their 
wishes in writing for issues such as reproductive choice and the court should enforce the 
advance agreements by using the plain meaning of the document); Litowitz v. Litowitz, 48 P.3d 
261 (Wash. 2002) (holding pre-embryos would be thawed as stated in the cryopreservation 
contract with the fertility clinic). Current precedent has recognized that the rights to procreate 
and to not procreate are significant, but generally the party that does not want to procreate is 
afforded protection. Id. See also Ellen Waldman, The Parent Trap: Uncovering the Myth of 
“Coerced Parenthood” in Frozen Embryo Disputes, 53 AM. U. L. REV. 1021 (2004) 
(discussing cases about the disposition of cryopreserved embryos, and whether the judicial 
precedent of avoiding unwanted genetic links between adults and biological children at all costs 
is appropriate).  
 30. See Kass, 696 N.E. 2d at 180. Common law principles of contract should be used to 
determine the intent and plain meaning of advance directive writings by the pro-genitors. Id.  
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altogether,31 over half of the states have restricted sale of human 
embryos for research,32 and one state explicitly allows the sale of 
embryos.33  
Fertility clinics offering ART are under very few statutory 
regulations regarding the creation, storage, or profit-making 
capabilities of the human embryos created in their clinics. Even the 
Fertility Clinic Success Rate and Certification Act,34 passed by 
Congress to require fertility clinics to publish their pregnancy success 
statistics and certify laboratories handling embryos, does not give 
investigators authority over clinical practices.35 The few standards 
that do exist are mostly derived from research review boards or non-
binding ethics committee guidelines.36  
 
 31. Florida and Louisiana explicitly prohibit the sale of embryos. FLA. STAT. ANN. 
§ 873.05 (LexisNexis 2006); LA. REV. STAT. ANN. § 9:122 (2006). Although Indiana classifies 
the sale of embryos as a felony, it provides an exception for those using the embryo for 
reproductive purposes. IND. CODE § 35-46-5-3 (2007). 
 32. State Embryonic and Fetal Research Laws, http://www.ncsl.org/ programs/health/ 
Genetics/embfet.htm (last visited Apr. 7, 2008). 
 33. VA. CODE ANN. § 32.1-289.1 (2006) (exempting ova from general ban on sale of body 
parts in Virginia). 
 34. Fertility Clinic Success and Certification Act, 42 U.S.C. § 263a-1 (2002). 
 35. Id. See ENCYCLOPEDIA OF REPRODUCTIVE TECHNOLOGIES 320–22 (Annette Burfoot 
ed., 1999) (Fertility Clinic Success and Certification Act has little control over any medical 
aspect of ART in fertility clinics).  
 36. See American Society for Reproductive Medicine, http://www.asrm.org (last visited 
Apr. 7, 2008). The American Society for Reproductive Medicine ethics committee has created 
minimum guidelines for consent. Ethics Committee of the American Society for Reproductive 
Medicine, Donating Spare Embryos for Embryonic Stem-Cell Research, 78 FERTILITY & 
STERILITY 957, 959 (2002). First, the consent process “should inform donors of the nature of 
embryonic stem cell derivation” and information about the research project, its potential 
commercial and medical applications, and confidentiality policies. Id. Second, the decision to 
donate embryos for research should occur after infertility needs are met or after discontinuation 
of therapy, unless the couple has explicit written instructions for future use of embryos. Id. at 
959–60. Third, a person other than the fertility treatment specialist should make any request for 
donations and make clear that it is not necessary for continued medical care. Id. Individuals 
requesting donation should make clear that the embryos will not be transferred to a woman’s 
uterus and reveal any financial incentives for the research. Id. Fourth, embryos “should not be 
bought or sold with a monetary exchange” but “[r]easonable fees may be charged for laboratory 
processing or for handling, storage, or transport of embryos.” Id.  
https://openscholarship.wustl.edu/law_journal_law_policy/vol27/iss1/11
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III. ORGAN DONATION AND REGULATION 
A. Organ Procurement Process 
Organ transplantation is an established medical practice giving 
many transplant recipients a chance for an otherwise impossible 
life.37 Organs can be donated by both the living and the deceased and 
is a voluntary decision.38 Living donors are often blood relatives who 
donate one or more of their organs to a family member.39 Decedent 
donors enter the organ donation process after they are declared brain 
dead.40 Once brain death occurs, an organ donation specialist comes 
to the treatment facility and determines whether the decedent would 
be a good candidate for organ donation.41 If so, the specialist then 
speaks to the decedent’s family about the possibility of organ 
donation.42 If the family decides to donate, then the decedent’s vital 
statistics are entered into a national registry to match the decedent’s 
organs to transplant recipients.43  
 
 37. Amy Vadenbroucke, HIV and Organ Donation: Illinois’ Solution to Organ Donation 
Shortages, 9 DEPAUL J. HEALTH CARE L. 1285, 1287–91 (2006) (discussing the development 
and history of organ donation, including federal and state laws). 
 38. Id. See generally Medline Plus: Organ Donation, http://www.nlm.nih.gov/ 
medlineplus/organdonation.html (last visited Apr. 7, 2008). Approximately 50% of kidney 
transplants and 8% of liver transplants are from live donors. Gary Becker & Julio Jorge Elías, 
Introducing Incentives in the Market for Live and Cadaveric Organ Donations 3 (George 
Stigler Center for the Study of the Economy and the State, Working Paper, 2003), available at 
http://home.uchicago.edu/~gbecker/MarketforLiveandCadavericOrganDonations_Becker_Elias.
pdf.  
 39. One method of increasing kidney transplants is exchanging donated kidneys of two 
willing donors with the appropriate blood-type of the other loved one’s transplant patients. Josh 
Fischman, Mix, Match, and Switch: Kidney Exchanges Between Strangers Are Helping to Ease 
the Organ Shortage, US NEWS & WORLD REP., Oct. 8, 2006, available at http://www.usnews. 
com/usnews/health/articles/061008/16organ.htm.  
 40. Life Gift, Understanding Donation: Organ Donation Process, http://www.lifegift.org/ 
lifegift/info/organ_donation_process/ (last visited Apr. 7, 2008) (describing the organ donation 
process of deceased donors from prior to death to completion of the transplant operation) 
[hereinafter Life Gift]. 
 41. Id. 
 42. Id. See also Brian Vastag, Need for Donor Organs Spurs Thought and Action, 287 
JAMA 2491 (2002) (discussing ideas of how to increase organ donation through use of 
presumptive scripts educating mourning families about the value of donation). 
 43. Life Gift, supra note 40; see also United Network for Organ Sharing: Organ Donation 
and Transplantation, http://www.unos.org/whatwedo/organcenter.asp (last visited Apr. 7, 2008) 
[hereinafter UNOS]. UNet is the national online database run by the UNOS. Id. The system 
registers patients for transplants, matches donated organs to waiting patients, and manages the 
Washington University Open Scholarship
p 247 Thomas book pages.doc  8/13/2008 9:30:00 AM 
 
 
 
 
 
 
 
 
 
254 Journal of Law & Policy [Vol. 27:247 
 
 
Families choose to donate for a variety of reasons, often because 
they derive comfort from the thought that their loved one’s body can 
be used to help others.44 The transplant recipient’s surgery team will 
then remove the organ(s) from the donor and transplant them into the 
recipient.45 Organ transplantation has become increasingly successful 
over the years, giving life to many who would otherwise not recover 
from life-terminating or debilitating illnesses.46  
B. Organ Transplantation and Donation Law 
1. National Organ Transplantation Act 
The donation of heart, kidney, pancreas, lungs, liver, and any 
other human organ specified by regulation as a solid organ is 
federally regulated under the National Organ Transplant Act 
(“NOTA”), enacted in 1984.47 NOTA heavily regulates the organ 
procurement industry, stipulating the methods of procurement, 
storage, and allocation of organs.48 NOTA criminalizes the sale of 
any human organ or tissue for profit.49 Violators face up to $50,000 
fees and a maximum of five years in prison.50 
 
data of all patients, before and after their transplants. Id. It is currently used by all of the 
nation’s organ transplant programs, OPOs, and tissue typing laboratories working to efficiently 
share a limited number of donated organs among many patients. Id. 
 44. Ohio Donor Registry, Stories, http://www.donatelifeohio.org/beahero/storiesfrom 
registrants/index.aspx (last visited Apr. 7, 2008).  
 45. Life Gift, supra note 40.  
 46. Life Gift, supra note 40. See generally Lauran Neergaard, Doctors Explore Use of 
Mismatched Hearts, WASH. POST, Feb. 12, 2007, available at http://www.washingtonpost.com/ 
wp-dyn/content/article/2007/02/12/AR2007021200833.html (explaining that babies have 
received mismatched heart transplants to increase their survival rate by taking advantage of a 
lag in their immune system); Roni Rabin, Prospect of Womb Transplant Raises Hopes and Red 
Flags, N.Y. TIMES, Jan. 30, 2007, at F5 (discussing the beginning of uterine transplants for 
women).  
 47. 42 U.S.C. §§ 273–274e (2000). 
 48. 42 U.S.C. § 273 (2000). 
 49. 42 U.S.C. § 274e(b) (2000). 
 50. Id. 
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In addition to several other provisions,51 NOTA created the Organ 
Procurement and Transplantation Network (“OPTN”), a national 
network facilitating organ donations around the country.52 OPTN 
matches organ donors with a patients’ need for organ transplantation 
through an established allocation system.53 To do so, OPTN uses 
organ procurement organizations (“OPO”), which are certified non-
profit, tax-exempt entities, with stringent guidelines for oversight and 
implementation.54  
OPOs identify organ donors, recover and process the organs, and 
prepare them for transplantation.55 Each OPO is designated to cover a 
particular area of the United States with a total of fifty-eight OPOs 
throughout the country.56 The Department of Health and Human 
Services (“DHHS”) designated the United Network of Organ Sharing 
 
 51. NOTA also provides a twenty-four hour phone service to facilitate the distribution of 
organs equitably among transplant patients and maintains procurement and screening standards 
of potential organs donated through UNOS and OPTN. 42 U.S.C. § 274(b)(2)(C) (2000). 
UNOS provides the twenty-four hour service staffed by organ placement specialists. United 
Network for Organ Sharing: Organ Donation and Transplantation—What We Do, 
http://www.unos.org/whatWeDo/organCenter.asp (last visited Apr. 7, 2008). NOTA aims to 
improve organ donation practices by increasing the number of donors, informing the public of 
donation needs, maintaining high procurement standards, and successfully matching transplant 
patients with available organs in a timely manner. See 22A AM. JUR. 2D Dead Bodies § 92 
(2003) [hereinafter Dead Bodies]; 42 U.S.C. § 274c(2) (2000).  
 52. See OPTN: Organ Procurement Transplantation Network, http://www.optn.org (last 
visited Apr. 7, 2008). 
 53. 42 U.S.C. § 274(b)(2) (2000); Dead Bodies, supra note 51. Potential transplant 
recipients are first ranked according to objective medical criteria such as blood or tissue type, 
size of organ, medical urgency, and time already spent on the waiting list. OPTN: Organ 
Procurement Transplantation Network, Donation and Transplantation, http://www.optn.org/ 
about/transplantation/transplantprocess.asp (last visited Apr. 7, 2008). Then potential recipients 
are ranked according to policy criteria that differ for each types of organ. UNOS, supra note 43. 
See also United Network for Organ Sharing: Organ Donation and Transplantation, 
http://www.unos.org/PoliciesandBylaws/policies.asp?resources=true (last visited Apr. 7, 2008). 
 54. 42 U.S.C. § 273 (2000). An OPO must prove its ability to maintain fiscal stability, 
must be certified every four years, and must have a defined service area sufficient to assure 
maximum effectiveness with staff able to complete such requirements to become a member of 
the Organ Transplantation Network. Id. OPOs must also have an advisory board composed of 
members representing (a) hospitals, tissue banks, and voluntary health associations; (b) the 
public; (c) physicians in the field of histocompatibility; (d) physicians with a speciality in 
neurology; and (e) a surgeon who has knowledge of organ transplantation with the authority to 
recommend procedures for organ procurement and transplantation. Id.  
 55. 42 U.S.C. § 273 (2000). See Robert A. Katz, The Re-gift of Life: Can Charity Law 
Prevent For-Profit Firms From Exploiting Donated Tissue and Nonprofit Tissue Banks?, 55 
DEPAUL L. REV. 943, 955–56 (2006).  
 56. Katz, supra note 55, at 955.  
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(“UNOS”)57 to become the private non-profit organization that 
maintains OPTN.58  
2. Uniform Anatomical Gift Act 
Although the method of procurement is federally regulated, the 
post-mortem process of donation is governed by individual states. All 
fifty states and the District of Columbia have enacted some version of 
Model Uniform Anatomical Gift Act (“UAGA”).59 Unlike the 
guidelines of NOTA, which are limited to organ procurement in 
practice, the UAGA also includes tissue donation.60 UAGA’s purpose 
is to overcome competing interests standing in the way of anatomical 
gifts at the time of death and increase the number of anatomical 
donations through policy-made incentives.61 It does so by setting 
standards of documentation for medical professionals to follow in the 
event of a death and to provide guidelines for gaining consent for 
organ and tissue procurement.62 Like NOTA, UAGA provides 
significant guidance to OPOs through regulations and oversight.  
C. Organ Sales of Living or Deceased Donors is Inappropriate 
With both living and deceased donors, procurement of organ 
donations raises ethical concerns.63 For living donors, the risks of a 
 
 57. UNOS, supra note 43.  
 58. Jeffrey A. McDaniel, Note and Comment, A Decent Proposal? Fundamental Fairness 
in an “Un-commercial” Organ System, 19 J.L. & COM. 327 (2000) (explaining the organ 
sharing network system and calling for stricter regulations for uniform and fair distribution of 
organs). 
 59. UNIF. ANATOMICAL GIFT ACT (amended 2006), 8A U.L.A. (Supp. 2007). This statute 
was first promulgated in 1968, revised in 1987, and most recently amended in 2006. Id. 
 60. Compare Id. prefatory note (referring to organ, eye, and tissue donations) with 42 
U.S.C. § 274b(d)(2) (2000) (referring only to organ donations).  
 61. UNIF. ANATOMICAL GIFT ACT prefatory note.  
 62. Id. See also Richard Perez-Pena, Turning the Grief-Stricken Toward Organ Donation, 
N.Y. TIMES, Jan. 16, 2007, at B1 (noting that the number of New York organ donors has 
increased by training nurses to talk to grieving families about donation).  
 63. See also David I. Flamholz, Note and Comment, A Penny for your Organs: Revising 
New York’s Policy on Offering Financial Incentives for Organ Donation, 14 J.L. & POL’Y 329, 
339–40 (2006); Michele Goodwin, Altruism’s Limits: Law, Capacity, and Organ 
Commodification, 56 RUTGERS L. REV. 305 (2004) (addressing organ and tissue donation and 
the limits of altruism and the subsequent private (illegal) donation processes that abound, and 
also comparing slavery to organ procurement programs).  
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serious medical procedure and the harm inflicted by the actual 
donation process weigh against medical professionals’ duty to not 
harm their patients.64 In addition, the use of living donors may create 
incentives to take advantage of individuals who are poor, desperate, 
young, or mentally incompetent and incapable of truly consenting to 
such a procedure.65 Because of the ethical issues surrounding living 
donors, deceased donor organ transplantation is the preferred method 
of donation, despite  its own ethical issues such as organ shortage.66 
However, in 2004 and 2005, the number of living donors exceeded 
deceased donors.67 As a result of lawmakers’ response to significant 
fears, particularly with respect to living donors, organ procurement 
and donation agencies in the United States are legally required to be 
non-profit entities and are absolutely prohibited from selling organs.68  
1. Selling Organs Devalues Intrinsic Human Worth  
The sale of organs places economic value upon human body 
parts.69 The widely held belief that selling human body parts 
promotes devaluation of an individual’s personhood and intrinsic 
 
 64. Flamholz, supra note 63, at 339–40 (discussing ethical concerns for organ donation 
from living and deceased donors). 
 65. See, e.g., Scott Carney, Indians Buy Organs With Impunity, WIRED NEWS, Feb. 8, 
2007, available at http://www.wired.com/news/technology/medtech/0,72675-0.html?tw=wn_ 
index_14. Flamholz, supra note 63, at 339–40.  
 66. Flamholz, supra note 63, at 341–42.  
 67. Jane E. Brody, For Living Donors, Many Risks to Weigh, N.Y. TIMES, Sept. 4, 2007, 
at F7.  
In 2004 and 2005, the number of organ donations from living donors surpassed those 
from dead donors. And although dead donors are once again more common, many 
people risk surgery and the loss of an organ to save the lives of people they love—and 
increasingly of strangers, as well. 
Id.  
 68. See supra notes 47–50 and accompanying text. One commentator has found five 
reasons to prohibit organ sale: (1) It causes harm to organ vendors; (2) Free donation expresses 
and promotes social solidarity, while allowing paid donation damages these values; (3) Organ 
donor consent is likely to be invalid; (4) Prospective organ vendors would be coerced into 
selling their organs; and (5) Organ vendors would be exploited. STEPHEN WILKINSON, BODIES 
FOR SALE: ETHICS AND EXPLOITATION IN THE HUMAN BODY TRADE 103 (2003). This Note will 
only focus on the effect of commodification on society’s view of the human body, undue 
influence and the validity of consent, and equitable dispersing of organs. 
 69. Id. at 101–07.  
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value led to the non-profit status of OPOs.70 Organ commodification 
encourages separating human bodies from our personhood, identity 
and personality71 and result in “strip[ping] the human body of its 
proper dignity” because human beings automatically connect bodies 
to “human personality and identity.”72 Payment for human organs 
threatens the basic principle that individuals should not become 
fungible products that are used to benefit others.73 Commodification 
would result in potential organ recipients—and the donors (dead or 
alive) themselves—viewing the donor as mere body parts to be sold 
or procured for personal gain.74 At the very least, organ sale 
symbolically violates personhood.75 As a result, many international 
 
 70. Fred H. Cate, Human Organ Transplantation: The Role of Law, 20 IOWA J. CORP. L. 
69, 80 (1994). Cate states,  
Congress apparently was galvanized into action banning the sale of human organs and 
tissues largely in response to a plan by H. Barry Jacobs, who established a company in 
Virginia to broker human kidneys . . . Jacobs . . . intended to broker kidneys from 
healthy, living donors at an agreed-upon price to which Jacobs would add $2,000 to 
$5,000 for his services. Jacobs testified before Congress that he also intended to bring 
Third World indigents to the United States so that the company could sell their 
kidneys. Congress responded by banning the sale of human organs and tissues. 
Id. The World Health Organization (“WHO”) guidelines, which emphasize voluntary donation, 
non-commercialization, and a preference for cadavers over living donors heavily influence 
worldwide legislation and policies for transplantation. World Health Organization, Human 
Organ and Tissue Transplantation, http://www.who.int/ethics/topics/human_transplant/en/ (last 
visited Apr. 7, 2008). 
 71. For example, “An attacker cannot plausibly plead: ‘I did not intend to hurt you, but 
only your body.’” Carson Holloway, Monetary Incentives for Organ Donation: Practical and 
Ethical Concerns, in ORGAN AND TISSUE DONATION 143, 152 (Bethany Spielman ed., 1996). 
“Bodies are more than mere objects insofar as they are intimately related to persons.” 
Wilkinson, supra note 68, at 53 (emphasis added).  
 72. Bernard Teo, Is the Adoption of More Efficient Strategies of Organ Procurement the 
Answer to Persistent Organ Shortage in Transplantation? 6 BIOETHICS 113, 125 (1992). Teo 
states that because we connect human bodies to human personality and identity,  
[I]t follows that respect for the human person would also be intrinsically tied to respect 
for the human body and its parts. . . . Because human dignity is intrinsically linked to 
human embodiment, treating the body and its parts as commodities would be to strip 
the human body of its proper dignity. 
Id.  
 73. Holloway, supra note 71, at 152; WILKINSON, supra note 68, at 44–48. One example 
of wrongful commodification is slavery, where a person is not valued for their humanity but 
only for their ability to work. 
 74. Holloway, supra note 71, at 152. 
 75. See Stephen Wilkinson, Commodification Arguments for the Legal Prohibition of 
Organ Sale, 8 HEALTH CARE ANALYSIS 189 (2000), available at http://www.springerlink.com/ 
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bodies76 and almost every country have taken the position that the 
sale of organs is ethically unacceptable.77 
Proponents of organ sale claim that commodification is a weak 
argument. They distinguish respect for personhood78 from individuals 
using their bodies in a useful manner.79 Respect for personhood, 
according to the theory, could be maintained while commercializing 
organs as long as the ability to be useful is not isolated from 
knowledge that the individual is an intrinsically valuable person.80 As 
an example, proponents point to the employment context where 
human labor is used as a fungible good without decreasing human 
dignity or value.81 Proponents also argue that the organ recipient’s 
 
content/w267652725386043/fulltext.pdf. 
 76. International bodies include the Transplantation Society, WHO, and the Council of 
Europe. See The Transplantation Society, Policy and Ethics, http://www.transplantation-
soc.org/policy.php (last visited Apr. 8, 2008); World Health Organization, Human Organ and 
Tissue Transplantation, http://www.who.int/ethics/topics/human_transplant/en/ (last visited 
Apr. 8, 2008); Parliament and Council Directive 2004/23, Setting Standards of Quality and 
Safety for the Donation, Procurement, Testing, Processing, Preservation, Storage and 
Distribution of Human Tissues and Cells, art. 12, 2004 O.J. (L 102) 48 (EC), available at 
http://www.who.int/ethics/en/ ETH_EU_Directive_2004_23_EC.pdf.  
 77. See, e.g., AUSTEN GARWOOD-GOWERS, LIVING DONOR ORGAN TRANSPLANTATION: 
KEY LEGAL AND ETHICAL ISSUES, ix–xi (1999) (discussing several countries’ policies on organ 
procurement, including Tables of Legislation of relevant legislation about organ and tissue 
donation); DAVID PRICE, LEGAL AND ETHICAL ASPECTS OF ORGAN TRANSPLANTATION, x–xiv, 
369 (2001) (Table of legislation regarding organ and tissue laws worldwide). Some countries, 
however, turn a blind eye to any organ commercialization activities despite the wide-spread 
prohibition of such activity. WILKINSON, supra note 68, at 101, 104–07 (discussing China’s 
practice of executing prisoners to harvest organs). This has created an international black 
market for organs. See DAVID J. ROTHMAN, Bodily Integrity and the Socially Advantaged, in 
ORGAN AND TISSUE DONATION, supra note 71, at 35, 37. The most notorious black markets are 
located in India and China where potential organ recipients from all over the world travel to 
receive often unethically procured organs. See id.; World Health Organization, Human Organ 
and Tissue Transplantation, http://www.who.int/ethics/topics/human_transplant/en (last visited 
Apr. 8, 2008). 
 78. Respect for personhood requires treatment of each person as a “unique individual” 
having “incommensurable value.” Wilkinson, supra note 75, at 196. 
 79. Wilkinson uses the example of recognizing a friend as highly useful for their 
household skills and recognizing the person as intrinsically valuable. Wilkinson, supra note 75, 
at 196. 
 80. Wilkinson, supra note 75, at 197–98.  
 81. Wilkinson, supra note 75, at 197–98. See also Stephen Wilkinson & Eve Garrard, 
Bodily Integrity and the Sale of Human Organs, 22 JOURNAL OF MEDICAL ETHICS, 334, 337 
(1996). 
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attitude toward a donor, as a means of personal gain, is identical 
regardless of compensation.82  
2. Sale of Body Parts May Unfairly Distribute Limited Organs 
Based on Income Rather than Necessity 
Many legal scholars, among others, have argued that relying 
solely upon the altruistic nature of humans is not enough to meet the 
demand for organ donation at this time.83 However, allowing sale of 
organs to compensate for the lack of organs also introduces a high 
likelihood of inequitable distribution of organs.84 The poor will rarely 
receive an organ transplant and bear the brunt of donation while the 
wealthy will receive organs but rarely donate.85  
 
 82. Wilkinson, supra note 75, at 194–95.  
 83. See Steve P. Calandrillo, Cash for Kidneys? Utilizing Incentives to End America’s 
Organ Shortage, 13 GEO. MASON L. REV. 69 (2004) (encouraging payment for organ 
donations); Joel D. Kallich & Jon Merz, The Transplant Imperative: Protecting Living Donors 
from the Pressure to Donate, 20 IOWA J. CORP. L. 139, 144 (1994); Christy M. Watkins, A 
Deadly Dilemma: The Failure of Nations’ Organ Procurement Systems and Potential Reform 
Alternatives, 5 CHI.–KENT J. INT’L. & COMP. L. 1 (2005) (discussing several alternatives to 
increase the number of donated organs and the history of organ donor procurement); Gail L. 
Daubert, Note and Comment, Politics, Policies, and Problems with Organ Transplantation: 
Government Regulation Needed to Ration Organs Equitably, 50 ADMIN. L. REV. 459 (1998) 
(describing the current system of organ distribution, discussing problems with that system, and 
suggesting that a government rationing system is necessary); Flamholz, supra note 63, at 329 
(outlining NOTA and AUGA and state laws relating to organ donation and then offering 
suggestions to increase the number of donated organs); Shelby E. Robinson, Comment, Organs 
for Sale? An Analysis of Proposed Systems for Compensating Organ Providers, 70 U. COLO. L. 
REV. 1019 (1999) (discussing ethical and practical considerations regarding monetary 
compensation to organ providers); Laurel R. Siegel, Comment, Re-engineering the Laws of 
Organ Transplantation, 49 EMORY L.J. 917 (2000) (proposing that Congress amend NOTA to 
include pilot programs that could increase the number of donated organs).  
 84. It is argued that organs are already inequitably distributed. Proponents of 
commercializing organ procurement argue there are ways to make distribution equitable in a 
manner other than non-payment. Adam J. Kolber, A Matter of Priority: Transplanting Organs 
Preferentially to Registered Donors, 55 RUTGERS L. REV. 671 (2003); Daubert, supra note 83; 
McDaniel, supra note 58; Robinson, supra note 83. 
 85. Most Indians who sell kidneys do so to pay off debts. Lawrence Cohen, Where it 
Hurts: Indian Material for an Ethics of Organ Transplantation, 38 ZYGON 663 (2003) 
(arguing that most people who sell their organs (mainly kidneys) in India do so in order to pay 
already existing debts and most “donors” are back in debt soon after the operation); Madhav 
Goyal et al., Economic and Health Consequences of Selling a Kidney in India, 288 JAMA 
1589, 1589–93 (2002). 
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3. Income from Organ Donation May Create Undue Inducement 
for Donation from Vulnerable Populations 
If commercialization of organ procurement were acceptable, it 
would prey upon indigent members of our society or the Third World 
as a source of organs.86 Any decision to donate organs should be 
voluntary,87 but financial incentives can compromise the 
voluntariness of donors.88 Vulnerable populations, particularly living 
donors, bear the brunt of this risk of undue inducement.89  
Inappropriately influenced decisions to sell organs by live donors 
may disproportionately affect low-income individuals because of 
financial need. A high number of low-income or vulnerable 
individuals responding to requests for organs might also raise 
questions about the quality of donated organs.90 However, those who 
 
 86. See supra notes 77 and 85 and accompanying text; Flamholz, supra note 63, at 329, 
339–40. 
 87. The Transplantation Society proposed that “[t]he person who gives consent to be a 
live organ donor should be competent, willing to donate, free of coercion, medically and 
psychosocially suitable, fully informed of the risks and benefits as a donor, and fully informed 
of risks, benefits, and alternative treatment available to the recipient.” The Transplantation 
Society Policy & Ethics, http://www.transplantation-soc.org/policy.php (last visited Apr. 8, 
2008). Consent is an ethical necessity, analogous to consent requirements for research subjects. 
CARL COLEMAN ET AL., THE ETHICS AND REGULATION OF RESEARCH WITH HUMAN SUBJECTS 
apps. D, E, F (2005). The Belmont Report and the Nuremberg Code require voluntariness of 
human research subjects because of the risks associated with research. Id. at apps. D-1, F-3. 
Organ procurement from live donors should follow similar standards. Peter P. Reese et al., 
Creating a Medical, Ethical, and Legal Framework for Complex Living Kidney Donors, 1 
CLINICAL J. AM. SOC. NEPHROL. 1148, 1148–53 (2006). A recent press release by the WMA 
condemned China’s practices that violate vulnerable populations. Press Release, World Medical 
Association, World Medical Association demands China stops using prisoners for organ 
transplants (May 22, 2006), available at http://www.wma.net/e/press/2006_4.htm.  
 88. Robert D. Truog, The Ethics of Organ Donation by Living Donors, 353 NEW ENGL. J. 
MED. 444, 445 (2005). 
 89. Joel D. Kallich & Jon Merz, supra note 83 at 139, 144. China often relies upon 
executed prisoners for organs, particularly hearts and kidneys. See Rothman, supra note 77, at 
35, 37. Although not publicly admitted, the government may sanction the death penalty based 
on organ transplant demand. Id.; WILKINSON, supra note 68, at 44–49; GARWOOD-GOWERS, 
supra note 77, at 149, 184–85 (discussing the high likelihood of coercion for organ procurement 
in vulnerable populations such as psychiatric patients, children, and mentally incompetent and 
U.S. cases of living donors who are adult incompetents); Price, supra note 77, at 367.  
 90. Fortunately, the fear of sub-par donated organs from impoverished individuals is 
tempered by the requirements that have been put in place for living donors. These requirements 
include physical fitness, good general health, and no high blood pressure, diabetes, cancer, 
kidney disease, or heart disease. Transplant Living: Organ Donor and Transplant Information 
for Patients, http://www.transplantliving.org/livingdonation/facts/qualifications.aspx (last 
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desire to procure organs may be tempted to ignore such concerns 
because of their immediate need.91 Unlike deceased donors, living 
donors are exposed to unknown medical risks involved in organ 
removal.92 In such cases, true consent for organ donations should be 
questioned.93 All of these issues—consent, coercion, and quality of 
donors—discourage commercializing organs via compensation.  
IV. TISSUE DONATION PROCUREMENT AND REGULATION 
A. Procurement of Tissues 
Tissue donors can be living or deceased.94 In the hospital context, 
deceased tissue donation is almost identical to organ donation.95 
Outside of the hospital context, tissue banks receive information from 
a variety of sources, including the coroner, funeral home directors, or 
medical examiners, for potential tissue donors.96 Approximately one-
half of prospective donors are rejected, but the tissue of those that are 
suitable is recovered without delay.97 Unlike organ procurement, 
 
visited Apr. 11, 2008). Cf. NORA MACHADO, USING THE BODIES OF THE DEAD: LEGAL, 
ETHICAL AND ORGANIZATIONAL DIMENSIONS OF ORGAN TRANSPLANTATION 192 (1998) 
(“[D]onation motivated by altruism is a means of assuring quality control . . . .). 
 91. See Sadaqat Jan, Poor Pakistanis Donate Kidneys for Money, WASH. POST, Nov. 12, 
2006, available at http://www.washingtonpost.com/wp-dyn/content/article/2006/11/12/ 
AR2006111200375.html; Nima Sarvestani, Iran’s Desperate Kidney Traders, BBC ONLINE, 
Oct. 31, 2006, available at http://news.bbc.co.uk/2/hi/programmes/this_world/6090468.stm.  
 92. Reese et al., supra note 87, at 1150; Kallich & Merz, supra note 83, at 147–48. 
 93. Kallich & Merz, supra note 83, at 144–45; Machado, supra note 90. 
 94. See Barbara Indech, The International Harmonization of Human Tissue Regulation: 
Regulatory Control Over Human Tissue Use and Tissue banking in Select Countries and the 
Current State of International Harmonization Efforts, 55 FOOD & DRUG L.J. 343, 345–46 
(2000) (discussing considerations for procurement of tissue from live donors). 
 95. See Ohio Organ and Tissue Procurement, Donation Process, http://www.donatelife 
ohio.org/aboutdonation/donationprocess/ (last visited Apr. 11, 2008) [hereinafter Donate Life 
Ohio].  
 96. See, e.g., Regeneration Donor Services, Medical & Funeral Professionals, 
http://www.rtidonorservices.com/en/professionals/professionals.aspx (last visited Apr. 11, 
2008). See generally Katz, supra note 55, at 959–61 (providing general information about tissue 
recovery and types of recoverable tissues).  
 97. John J. Zodrow, The Commodification of Human Body Parts: Regulating the Tissue 
Bank Industry, 32 SW. U. L. REV. 407, 407, 411–12 (2003) (discussing the tissue procurement 
process, types of tissue recoverable including corneas, veins, nerves, bone, cartilage, tendons, 
skin, and marrow). The amount of recoverable tissue from one body exceeds the number of 
recoverable organs. Cf. id.  
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tissue can be procured several hours after the patient’s death and can 
be stored for longer periods of time.98 Generally, donated tissue must 
be procured within twenty-four hours of the donor’s death.99 
After determining that the decedent is a suitable donor, the tissue 
bank or OPO specialist asks the family members about their 
willingness to donate.100 The tissue bank or OPO representative may 
or may not tell the family about the bank’s non-profit status.101 If the 
family chooses to donate, the tissue bank undergoes the retrieval 
process.  
B. Historical and Current Tissue Banking Oversight 
The first tissue bank in the United States was maintained by the 
United States Navy.102 As uses for donated tissue began to grow, 
additional tissue banks were started by physicians, researchers, and 
hospitals for use in their local communities.103 Over time, tissue 
banks were primarily non-profit entities that varied in size, with the 
largest tissue banks connected to medical institutions.104 In 1976, the 
American Association of Tissue Banks (“AATB”)105 was created to 
ensure quality standards, increase number of donations, support 
scientific exchange of ideas and provide adequate support for the 
tissue banks.106 The AATB is the only organization that accredits 
tissue banks; however, tissue banks are not required or expected to be 
accredited.107  
Today, the Food and Drug Administration (“FDA”) under the 
DHHS regulates the tissue-based products and consequently directly 
 
 98. Id. at 411–12. 
 99. Id. Tissue recovery times depend upon the type of tissue being recovered but range 
from several hours after death to a full day. Id.  
 100. Donate Life Ohio, supra note 95.  
 101. See generally Katz, supra note 55, at 959–61.  
 102. Jason L. Williams, Note, Patient Safety or Profit: What Incentives Are Blood Shield 
Laws and FDA Regulations Creating for the Tissue Banking Industry?, 2 IND. HEALTH L. REV. 
295–96 (2005). 
 103. Zodrow, supra note 97, at 411.  
 104. Williams, supra note 102, at 296–300; Zodrow, supra note 97, at 411–12.  
 105. AATB: American Association of Tissue Banks, http://www.aatb.org (last visited Apr. 
11, 2008). 
 106. Williams, supra note 102, at 296–300. Zodrow, supra note 97, at 411–12. 
 107. Williams, supra note 102, at 297. Zodrow, supra note 97, at 412–13. 
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affects the tissue banking industry.108 Under the FDA and DHHS, 
regulated tissues that are able to be donated include: 
Any tissue derived from a human body, which 1) [i]s intended 
for transplantation to another human for the diagnosis, cure, 
mitigation, treatment, or prevention of any condition or 
disease; 2) [i]s recovered, processed, stored or distributed by 
methods that do not change tissue function or characteristics; 
3) [i]s not currently regulated as a human drug, biological 
product, or medical device; 4) [e]xcludes kidney, liver, heart, 
lung, pancreas, or any other vascularized human organ and; 5) 
[e]xcludes semen or other reproductive tissue, human milk, 
and bone marrow.109  
The FDA’s regulatory power is derived from the DHHS, which is 
charged by the Public Health Service Act110 to ensure that tissues are 
not defective or contaminated during processing or transplantation.111 
Although the FDA has played different roles in its regulation of the 
tissue procurement industry, reducing risks to public health is one of 
its primary objectives.112 The most significant regulation enforced by 
the FDA classifies tissue that has been more than minimally altered, 
used for non-homologous use, or has been combined with another 
article, as a drug or medical device that has more stringent 
requirements due to public health reasons.113 However, most cases 
involving tissue are regulated only to the extent that prevents 
communicable diseases.114  
Just as the regulatory construction for tissue procurement has 
changed over the years, so has the tissue banking industry.115 The 
 
 108. Zodrow, supra note 97, at 412–13. 
 109. Indech, supra note 94, at 343 (quoting Human Tissue Intended for Transplantation, 21 
C.F.R. § 1270 (1999)) (emphasis added).  
 110. 42 U.S.C. §§ 201–300 (2000).  
 111. FDA/CBER Testing HCT/P Donors for Relevant Communicable Disease Agents and 
Diseases, http://www.fda.gov/cber/tissue/prod.htm (last visited Apr. 11, 2008).  
 112. DEP’T OF HEALTH AND HUMAN SERVS., FOOD AND DRUG ADMIN., PUBL’N NO. FS 01-
4, FDA’S CENTER ON THE FRONT LINE OF THE BIOMEDICAL FRONTIER (2002), available at 
http://www.fda.gov/opacom/factsheets/justthefacts/4cber.pdf; Indech, supra note 94, at 347.  
 113. Williams, supra note 102 at 301.  
 114. Id. at 302. 
 115. Williams, supra note 102, at 297–99. 
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industry has seen explosive growth from its historical community-
based tissue banking model and its non-profit roots.116 Although the 
sale of tissue is still strictly prohibited by federal law, current 
legislation allows profit to be made in the processing of donated 
tissue.117 This has created a little-known multi-billion dollar profit-
earning industry dependent primarily upon the altruistic donation of 
tissues to hospitals and other tissue banks.118 These tissue processors, 
many of them publicly traded companies, create products from the 
donated tissue that are used in a variety of ways and are highly 
profitable.119  
Tissue procurement and use is not as strictly regulated as organ 
donation.120 Thus, most community tissue banks send their tissues to 
be processed at a processing company and collect a recovery fee from 
the processing company.121 Processing companies can be either profit 
or non-profit, but a growing number are profit earning 
corporations.122 For-profit tissue processing companies make 
 
 116. Williams, supra note 102, at 297–99. “For example, 350,000 human tissue products 
were transplanted in 1990; however, more than 800,000 tissue products were transplanted in 
2002.” Id. at 298.  
 117. Williams, supra note 102, at 297–99. This differs from organ processing companies, 
that must be non-profit entities. Although 42 U.S.C. § 274e defines organs to include tissue and 
the statutes referring to OPO’s do not redefine organs, it seems that the government does not 
enforce or interpret the definition of human organs to include tissue, and thus it does not require 
the same standards for tissue regulation as it does for organ donation. 42 U.S.C. § 273 (2000); 
see also Katz, supra note 55, at 946–47. 
 118. One of the largest tissue product companies is Cryolife, a leader in processing heart 
valves and other tissue products, with $40 million in worldwide 2006 sales of one of its more 
popular products. Cryolife-CorporateProfile, http://phx.corporate-ir.net/phoenix.2html?c=80253 
&p=irol-homeProfile&t=&id=& (last visited Apr. 11, 2008). Osteotech and Lifecell are two 
other tissue processing companies making millions in net revenues yearly. Osteotech-Financial 
Highlights, http://www.osteotech.com/finhi.htm (last visited Apr. 11, 2008); Lifecell, Annual 
Report (2004), http://lifecell.com/downloads/annual/2004%20Annual%20Report%20with% 
2010-K.pdf. Lifecell reported product revenues from cadaveric tissues used for plastic 
reconstructive surgery, burn victims and others of $32.9 million in 2002, $38.6 million in 2003 
and $58.7 million in 2004. Lifecell, supra. Osteotech claims to be a global leader in processing 
human bone and connective tissue for transplantation and receives close to $100 million in net 
revenues in 2003–2005. Osteotech, supra. It is estimated that the total amount of revenue for 
tissue processing companies is over $1 billion. See Williams, supra note 102, at 297–99.  
 119. Williams, supra note 102, at 297–99. Cryolife, Osteopath, and Lifecell are all publicly 
traded multimillion dollar revenue earning tissue processing companies. See supra note 118. 
 120. 42 U.S.C. § 274e (2000). NOTA only includes tissue donation in the statutory 
language relating to sale of body parts. Id. See supra note 117.  
 121. Williams, supra note 102, at 297–99. 
 122. The largest suppliers of implantable human tissue are MTF Foundation, Regeneration 
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significant revenue by selling “tissue service” to hospitals.123 This 
new tissue processing system has dramatically changed the face of 
tissue banking from one of altruism to that of significant profit.124  
C. The Effect of Profit on Tissue Banks 
Revenue earning tissue processing companies have changed the 
completely charitable nature of the tissue donation industry,125 but 
they have also garnered great technological advancements for 
medical uses of the donated tissue.126 Donated tissue is often used for 
allografts,127 such as cryopreserved heart valves for patients with 
defective heart functions,128 demineralized bone matrices for spinal 
fusion surgeries,129 and acellular dermal tissue to replace skin for 
burn and cancer victims without the patient’s body rejecting the new 
skin.130 Acellular dermal tissue can also be used for cosmetic surgery, 
such as the reduction of wrinkles.131 These are just a few of the 
 
Technologies, Osteotech, Is Otis, and CryoLife. Robin R. Young, FDA Issues Final Good 
Tissues Practices Rule, http://www.healthpointcapital.com/research/2004/11/29/fda_issues_ 
final_good_tissue_practices_rule/ (last visited Apr. 11, 2008).  
 123. Williams, supra note 102, at 297–99. 
 124. See generally Katz, supra note 55, at 943–52. 
 125. Tissue processing companies often partner with community banks so that they can 
have reliable access to human body tissues. Williams, supra note 102, at 299.  
 126. See generally Katz, supra note 55, at 963–67. 
 127. LifeLink Tissue Bank, Frequently Asked Questions and Answers, http://www.life 
linktb.org/index.cfm/fuseaction/index.cfm?fuseaction=Patients.FAQs (last visited Apr. 11, 
2008) (defining allograft as a “tissue (i.e. bone, ligaments, heart valves) recovered from a 
human donor for transplantation into another person.”). 
 128. LifeLink Tissue Bank, About Tissue Donation, http://www.lifelinktb.org/index.cfm/ 
fuseaction/Patients.About (last visited Apr. 11, 2008) (“Heart valves are used in cardiovascular 
surgery for patients with valvular disease.”); see also Cryolife: Corporate Profile, 
http://www.cryolife.com/about/profile/ (last visited Apr. 11, 2008) (Cryolife, a for-profit tissue 
processing company was the first to develop a commercially viable cryopreserved heart valve.).  
 129. Bone Graft Options for Spine Fusion Surgery, http://www.spine-health.com/topics/ 
surg/bone/bone02.html (last visited Apr. 11, 2008) (donor allograft bones work well in the 
upper spine (neck) area). See also Osteotech, The Grafton Advantage, http:// 
www.osteotech.com/prodgrafton.htm (last visited Apr. 11, 2008) (observing that Osteotech 
currently dominates as the demineralized bone matrix supplier, but is facing growing 
competition).  
 130. LifeLink Tissue Bank, About Tissue Donation, supra note 128 (“Transplanted skin is 
used as replacement tissue over 1,000,000 times per year. Three quarters of this usage occurs in 
life-saving circumstances such as severe burns.”). 
 131. AlloDerm by Life Cell is one such cadaveric tissue that is often used for cosmetic and 
facial reconstructive surgery. Alloderm Defined, http://www.lifecell.com/products/95/ (last 
https://openscholarship.wustl.edu/law_journal_law_policy/vol27/iss1/11
p 247 Thomas book pages.doc  8/13/2008 
 
 
 
 
 
 
 
 
 
2008]  A Regulated Fertility Industry 267 
 
 
medical advances that have been made by pharmaceutical companies 
processing donated tissue.132 Many of these processes are patented by 
large commercial tissue processors that are unable to keep up with 
the growing demand133 and gain significant profit from selling the 
products to hospitals.134  
It is hard to know whether these advances would have taken place 
without the entrance of profit-based companies in the tissue industry. 
American society encourages ingenuity through capitalism, and 
without profit as an incentive for medical advancement, the funds and 
resources necessary to create valuable medical products may not have 
been provided or used to save many patients’ lives. Also, the belief 
that tissue is procured through truly voluntary consent is questionable 
if it is not clear that tissue donors are aware of the profits derived 
from their altruistic actions.135 California has enacted a statute 
requiring tissue procurement agencies to reveal to potential donors 
their intended use of the tissue, and whether monetary profit will be 
gained from the donor’s altruism.136 There is mixed speculation about 
 
visited Apr. 11, 2008).  
 132. Tissue Services, http://www.lifecell.com/tissue (last visited Apr. 11, 2008). Cadaveric 
tissue can be used in the following ways:  
[T]issue transplants make possible skin grafts for thousands of critically burned 
patients and others in need of soft tissue repair; donated corneas avert or correct 
blindness; donor heart valves help repair cardiac defects or damage; bone, cartilage 
and tendon grafts help restore function in people who would otherwise be 
incapacitated or disabled. 
Id. 
 133. Aaron Smith, Tissue From Corpses in Strong Demand: Market for Allografts Keeps 
Growing, Outpacing Supply, CNN MONEY, Oct. 5, 2005, available at http://money.cnn.com/ 
2005/10/04/news/midcaps/allograft/index.htm.  
 134. Katz, supra note 55, at 943, 963–67.  
 135. Kevin L. J. Oberdorfer, The Lessons of Greenberg: Informed Consent and the 
Protection of Tissue Sources’ Research Interests, 93 GEO. L.J. 365 (discussing tissue collection 
and informed consent in research and therapeutic settings and applying it to the facts in 
Greenberg v. Miami Children’s Hosp. Research Inst., Inc. 264 F. Supp. 2d 1064 (S.D. Fla. 
2003)). 
 136. CAL. HEALTH & SAFETY CODE § 7158.3(b)(1) (Deering 2006); see SHERRY AGNOS, 
CAL. SEN. OFFICE OF RES., TISSUE DONATIONS: ISSUES AND OPTIONS IN OVERSIGHT, 
REGULATION AND CONSENT 11 (2003), available at http://www.sor.govoffice3.com/ (select 
“Publications” tab; then follow “By Subject Area” hyperlink; then follow “Health” hyperlink) 
(stating that unless families are made aware of for-profit or non-profit status, it may be 
“difficult to assert that genuine informed consent was obtained”). See also Katz, supra note 55, 
at 957–59; Julia D. Mahoney, The Market for Human Tissue, 86 VA. L. REV. 163 (asserting that 
Washington University Open Scholarship
p 247 Thomas book pages.doc  8/13/2008 9:30:00 AM 
 
 
 
 
 
 
 
 
 
268 Journal of Law & Policy [Vol. 27:247 
 
 
whether the number of donors will decrease if the commercial uses 
and profits were revealed, particularly because none of the profit is 
passed to the altruistic donor.137 Other states may follow California’s 
actions138 and DHHS proposed a regulation, which was enacted, that 
requires disclosure about the tissue bank’s profit status.139  
V. APPLYING ORGAN OR TISSUE PROCUREMENT REGULATIONS TO 
EMBRYO TREATMENT 
As the existing numbers of cryopreserved embryos grow,140 
federal statutes should be enacted to protect potential donors and their 
embryos. The impact of organ and tissue procurement laws provides 
different levels of protection for the donor.141 The differences may be 
attributed to their respective functions and the typical recipient of 
such donations. Comparing tissue and organ characteristics and 
evaluating tissue and organ procurement regulations and effects if 
applied to human embryo procurement may help create appropriate 
regulations for human embryo treatment.  
Human embryos share characteristics similar to both tissues and 
organs. Embryo creation outside the womb occurs when all other 
efforts of procreation have failed;142 likewise, organ transplants are 
considered when no other alternative exists.143 Also like organs, 
human embryos have the power to sustain human life. The capability 
 
markets in human biological materials exist and are unavoidable and instead the conversation 
should be about the allocation of burdens and benefits of scientific advances).  
 137. Alison Jack & Christopher Womack, Why Surgical Patients Do Not Donate Tissue 
For Commercial Research: Review of Records, 327 BRIT. MED. J. 262 (2003) (stating that in a 
study of over 3,000 interviews, only 1.2% of responders refused to donate tissue based on its 
commercial use after donation).  
 138. See Katz, supra note 55, at n.93 (similar bill was supported by twenty-four Wisconsin 
legislators). 
 139. 70 Fed. Reg. 6086, 6119 (Feb. 4, 2005) (codified as amended at 42 C.F.R. 
§ 486.342(4) (2006)). DHHS’ proposal included requiring the OPO to give the potentially 
donating family “information (such as profit or non-profit status) about organizations that will 
recover, process, and distribute tissue” in its proposed legislation. Id.  
 140. See supra notes 17, 20–24 and accompanying text. 
 141. See supra Parts III.B, IV.B. 
 142. See supra note 7 and accompanying text. 
 143. See supra Part III.A. Similar to transplanted organs that replace a vital life-sustaining 
organ, embryos contain everything necessary to bring forth a human child within its cells. See 
supra Part II.A.  
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of human embryos to preserve life without any negative effects to the 
donor and their unlimited availability is similar to tissue.144 However, 
unlike current regulations for organ or tissue donation, 145 screening 
procedures are less stringent for embryo donation146 because embryos 
are created to become genetic offspring of a particular couple 
regardless of genetic disease.147  
Selling embryos presents many of the same issues that prompted 
legislators to prohibit monetary exchange for tissue and organs.148 
Allowing the sale of human embryos is even more troubling because 
it treats potential offspring as chattel—somewhat similar to the 
practice of slavery, which existed in parts of the United States prior 
to the Civil War.149 This practice devalues the intrinsic worth of 
humans, commodifies potential children, and might even encourage 
couples to buy the “best” child for their money.150 Because couples 
cannot separate the embryo’s value from its capabilities, arguments 
made by supporters of organ sale151 are inapplicable when it comes to 
the sale of human embryos. Furthermore, if abandoned or 
misappropriated human embryos are sold, fertility clinics are thus 
implanting genetic offspring without permission from, or notice to, 
the donating parents.152 Finally, economic need or pressure from 
fertility clinics may unduly influence a decision to sell an embryo.153  
Public policy required Congress to protect vulnerable organ 
donors and recipients with strict governance of organ procurement.154 
 
 144. See supra Parts II.A, IV.A, and notes 97–99 and accompanying text. Tissues do not 
face shortages as organs do because they do not have to be matched perfectly with the donor 
and each individual can donate larger amounts of tissue. Id. 
 145. See supra Parts III.B, IV.B. Couples are able to test for genetic diseases if they wish, 
but are often limited in what types of tests are available. See Palca, supra note 7.  
 146. See supra notes 12–13 and accompanying text. However, if sperm or other type of 
reproductive tissue is donated, it goes through strict screening measures. Id.  
 147. Cf. supra text accompanying note 13.  
 148. See supra notes 68–70 and accompanying text.  
 149. See Part III.C.1. Couples may also “bid” on embryos based on specific qualities and 
that sounds uncomfortably similar to slavery as well. Halloway, supra note 71 and 
accompanying text; see also Stein, supra note 22.  
 150. See supra notes 22–24 and accompanying text.  
 151. See supra Part III.C.1.  
 152. See supra notes 23–24 and accompanying text.  
 153. See supra notes 26, 28 and accompanying text.  
 154. See supra notes 47–58 and accompanying text. 
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Coerced organ donors155 and desperate recipients are subject to 
significant medical risks that are easily ignored during times of 
crisis.156 Similarly, parents desperate for a birthed child157 or the 
economic benefits of selling embryos for research are easily 
pressured by fertility clinics or others to buy or sell embryos.158 If 
human embryos were treated like tissue, profit-earning fertility 
clinics could encourage donation for the clinic’s own economic 
benefit, but its target market would be similar to organ recipients—
those desperate for a chance to live.159 Requiring all aspects of organ 
procurement to be non-profit, with significant oversight, aims to 
prevent schemes that prey upon the vulnerable; a similar plan could 
do the same for human embryo procurement.160  
Allowing profitable companies to process tissue and create 
marketable products from donated tissue has produced great gains in 
medical technologies.161 However, tissue procurement laws that allow 
for profits may also create an incentive for human embryo 
misappropriation by fertility clinics, which maintain physical control 
over embryos along with the opportunity for medical advances.162 If 
human embryo sales are not prohibited but profits gained by fertility 
clinics continue to be undisclosed, then there may be a question of 
true donative intent and an issue of inequitable enrichment.163  
 
 155. See supra notes 83–84 and accompanying text.  
 156. See supra note 85 and accompanying text. Medical risks include purchasing organs 
that do not match the recipient or is in poor condition. Id.  
 157. See supra note 6 and accompanying text.  
 158. See supra note 36 and accompanying text; infra notes 159–60.  
 159. See supra notes 118–19 and accompanying text. It must be noted, however, that tissue 
cannot be purchased or sold; only processing fees may be collected. Id. Also, tissue donation 
from cadavers does not present the same level of medical risks as organ or embryo 
procurement. Id.  
 160. See supra Part III.B. Strict federal oversight also discourages a black market and the 
health risks of procuring an organ off of the black market. Id.  
 161. See supra notes 127–32 and accompanying text.  
 162. See supra note 26 and accompanying text.  
 163. See supra notes 135–37 and accompanying text.  
https://openscholarship.wustl.edu/law_journal_law_policy/vol27/iss1/11
p 247 Thomas book pages.doc  8/13/2008 
 
 
 
 
 
 
 
 
 
2008]  A Regulated Fertility Industry 271 
 
 
VI. PROPOSED REGULATIONS FOR TREATMENT OF UNIMPLANTED 
EMBRYOS 
Potential parents should have control over their cryopreserved 
embryos, and their decision to donate should not be coerced by 
financial considerations. In order to do so, fertility clinics, which hold 
significant control over financially lucrative cryopreserved embryos 
and are in a position to exploit couples and embryos, must be 
statutorily regulated. Analyzing fertility clinics and embryo donation 
with current policies and statutes regulating organ and tissue donation 
has led to the following conclusions: (1) embryos should not be 
bought or sold in a monetary exchange, (2) donors’ decisions should 
be fully informed and truly voluntary, and (3) embryo procurement 
organizations should be non-profit and conform to standards similar 
to NOTA.  
Sale of human embryos should be illegal, and human embryos 
should be treated with special respect by their potential donors, as 
well as the couple or research facility to which they are donated.164 
Allowing commodification of embryos is even more damaging than 
organ sale because human embryo sale ignores any inherent worth 
embryos hold as genetic offspring of a couple. Whenever an embryo 
is sold, it commodifies the human embryo by placing its value only 
on its characteristics.165 This bears a horrific resemblance to slavery, 
where human beings are consistently dehumanized and valued only 
for embodying particular characteristics and functions.166  
Sale of human embryos encourages exploitation of vulnerable 
populations, and prohibition of such exchanges would promote the 
public policy of protecting vulnerable populations. Couples may turn 
to purchasing human embryos out of desperation for a child and are, 
therefore, particularly vulnerable to exploitation.167 Prohibiting 
human embryo sales prevents couples from taking inappropriate 
medical risks, bidding for the “best” child, or selling their embryos 
 
 164. See supra note 28 and accompanying text.  
 165. See supra notes 71–72 and accompanying text. 
 166. See supra note 73 and text accompanying notes 70–74. 
 167. This is similar to organ procurement which preys upon individuals desperate for an 
organ and donors desperate for monetary compensation. See supra notes 85–87 and 
accompanying text. 
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because of financial straits. Public policy supports statutory 
regulations that limit the power of fertility clinics, researchers, and 
potentially purchasing couples over a prospective donor to allow true 
consent.168  
Donation of embryos should be truly voluntary and can be 
ensured by a standardized consent process that must occur prior to 
the procedure. In order to facilitate voluntary consent, couples should 
be specifically asked, after completing fertility procedures, if their 
original decisions for or against donation remain unchanged. To 
prevent confusion, this decision should only be changed for one year 
after the couple’s infertility needs are met. Requests for donation 
should be made by specialists uninvolved in the treatment of the 
couple’s infertility needs and with assurances that the decision will 
not impact medical care in any way. If donating for research 
purposes, embryo donors should be informed of the embryonic stem 
cell derivation process, the sources of funding for any research, its 
potential commercial value and applications, and the confidentiality 
policies of the fertility clinic. If decisions to donate are contested at a 
later time, it is appropriate to follow applicable case law.169 
Regulating human embryo donation by instituting a statute similar 
to NOTA protects both donors and recipients. Fertility clinics are 
largely unregulated and maintain physical control over most human 
embryos derived from ART processes.170 Fertility clinics acting as 
embryo procurement and storage organizations should be non-profit, 
with accreditation requirements and standards that protect donors. 
Accreditation ensures that embryo procurement organizations are 
truly non-profit and also that there are adequate protections for 
potential donors and their embryo(s).  
Necessary embryo processing should also be conducted by non-
profit organizations to avoid the inequities and inappropriate 
practices that are growing in the tissue industry with little or no donor 
knowledge.171 It seems likely that the number of embryo donors who 
agree to give embryos for research purposes would decrease if the 
 
 168. See supra note 36 and accompanying text. 
 169. See supra note 28 and accompanying text. 
 170. See supra note 26 and accompanying text. 
 171. See supra notes 135–39 and accompanying text. 
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donors knew that their donated embryos were creating a profitable 
industry for fertility clinics. Any potential financial gain by 
researchers should be disclosed to the potential donors prior to their 
consent and should not provide a source of financial gain to the 
embryo procurement organization. However, similar to tissue and 
organ procurement organizations, appropriate fees for storage, 
processing, and transport may be charged if the minimal revenue is 
used to promote further education about human embryo donation.172  
VII. CONCLUSION 
Statutory protection for human embryo donation and processing is 
essential. Donors and human embryos alike need protection from 
misappropriation or use of embryos against the donors’ wishes. 
Prohibiting the sale of human embryos and accrediting embryo 
procurement and storage organizations as non-profit entities under 
strict regulations will effectively provide the necessary protection. 
 
 172. See supra notes 47–51 and accompanying text. 
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